Left Ventricular Noncompaction-A Systematic Review of Risk Factors in the Pediatric Population

Katarzyna Łuczak-Woźniak1, Bożena Werner2

  • 1Department of Pediatric Cardiology and General Pediatrics, Doctoral School, Medical University of Warsaw, 02-091 Warsaw, Poland.

Insights

Left ventricular noncompaction (LVNC) in children involves various risk factors for poor outcomes. Echocardiography, ECG, cardiac MRI, and genetic testing aid in identifying high-risk pediatric patients needing closer monitoring.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatric Medicine

Background:

  • Left ventricular noncompaction (LVNC) is a complex, often inherited cardiomyopathy with varied clinical presentations.
  • Understanding risk factors and diagnostic nuances in pediatric LVNC is critical for timely intervention.

Purpose of the Study:

  • To review risk factors for adverse outcomes in pediatric LVNC.
  • To discuss diagnostic modalities and differentiate pediatric from adult LVNC.
  • To identify children requiring heightened clinical attention.

Main Methods:

  • Systematic literature review of 1983 articles, with 23 meeting inclusion criteria.
  • Analysis of echocardiographic parameters (ejection fraction, dimensions, wall compaction, strains).
  • Evaluation of electrocardiogram (ECG) findings (T-wave, QRS-T angle, arrhythmia) and cardiac magnetic resonance (CMR) imaging (systolic dysfunction, late gadolinium enhancement).
  • Review of genetic testing associations with outcomes.

Main Results:

  • Echocardiographic findings like reduced ejection fraction and altered dimensions are linked to adverse outcomes in pediatric LVNC.
  • ECG abnormalities (T-wave changes, QRS-T angle) and arrhythmias indicate higher risk in children.
  • CMR effectively identifies systolic dysfunction and late gadolinium enhancement.
  • Specific gene mutations identified through genetic testing correlate with poorer prognoses.

Conclusions:

  • ECG and imaging (echocardiography, CMR) are vital for identifying risk factors and high-risk pediatric LVNC patients.
  • Genetic testing can aid in risk stratification for pediatric LVNC.
  • Refined diagnostic criteria are essential to prevent unnecessary activity restrictions in affected children.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
124
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
125
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.8K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
146
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
172
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
129